Health Canada is strengthening the required side effect warnings on prescriptions of Reglan so that they include more information regarding the likelihood of someone developing debilitating Tardive dyskinesia.
Reglan is the brand name of the drug Metoclopramide which has been used for decades to as an anti-emetic & prokinetic drug. Health Canada is the department which sets health policy within Canada. Health Canada has come out with stronger warnings regarding the major side effect of Tardive dyskinesia. The new warnings will now be required for all prescriptions of Reglan. Continue reading “Reglan Tardive Dyskinesia Side Effect Warnings Boosted In Canada” »